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Abstract
Background:  Although chromosome missegregation during oocyte maturation (OM) is a
significant contributor to human morbidity and mortality, very little is known about the causes and
mechanisms of aneuploidy. Several investigators have proposed that temporal perturbations during
OM predispose oocytes to aberrant chromosome segregation. One approach for testing this
proposal is to temporarily inhibit the activity of protein proteolysis during OM. We used the
reversible proteasome inhibitor MG-132 to transiently perturb the temporal sequence of events
during OM and subsequently analyzed mouse metaphase II (MII) for cytogenetic abnormalities. The
transient inhibition of proteasome activity by MG-132 resulted in elevated levels of oocytes
containing extra chromatids and chromosomes.
Results: The transient inhibition of proteasome-mediated proteolysis during OM by MG-132
resulted in dose-response delays during OM and elevated levels of aneuploid MII oocytes. Oocytes
exposed in vitro to MG-132 exhibited greater delays during metaphase I (MI) as demonstrated by
significantly (p < 0.01) higher levels of MI arrested oocytes and lower frequencies of premature
sister chromatid separation in MII oocytes. Furthermore, the proportions of MII oocytes containing
single chromatids and extra chromosomes significantly (p < 0.01) increased with MG-132 dosage.
Conclusions: These data suggest that the MG-132-induced transient delay of proteasomal activity
during mouse OM in vitro predisposed oocytes to abnormal chromosome segregation. Although
these findings support a relationship between disturbed proteasomal activity and chromosome
segregation, considerable additional data are needed to further investigate the roles of
proteasome-mediated proteolysis and other potential molecular mechanisms on chromosome
segregation during OM.
Background
Although numerous hypotheses have been proposed to
describe the etiology of aneuploidy in human gametes,
the only steadfast association remains maternal age [1,2].
Besides this association, very little information is availa-
ble about the numerous potential mechanisms that may
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disrupt normal chromosome segregation in oocytes.
Based on studies involving compounds that alter microtu-
bular kinetics and induce both cell-cycle delay and aneu-
ploidy, several groups have proposed that temporal
perturbations during mammalian oocyte maturation
(OM) predispose oocytes to aneuploidy [3–6]. In addi-
tion to faulty microtubule kinetics, perturbations during
OM may also stem from abnormal function of centro-
somes, kinetochores, spindle checkpoints proteins, the
anaphase-promoting complex (APC), the securin-separin-
cohesion complex proteins, and the proteasome [7].
OM encompasses the nuclear and cytoplasmic changes
that occur during the transition from the dictyotene stage
of meiosis I to metaphase II (MII). During this transition,
tightly-regulated post-translational phosphorylation-de-
phosphorylation events and proteasome-mediated prote-
olytic reactions regulate the activation and inactivation of
signal transduction pathways that control chromatin con-
densation, nuclear membrane dissolution, microtubule
nucleation, and formation of a haploid oocyte [8–10].
Several kinases that exert major roles during OM include
maturation promoting factor (MPF) [9,11], mitogen-acti-
vated protein kinases (MAPKs) [12,13], and the product
of the c-mos protooncogene Mos kinase [14,15]. Also,
during OM oocytes undergo two highly-regulated met-
aphase-anaphase transitions (MAT) in which homolo-
gous chromosomes are equally and randomly segregated
to an oocyte and first polar body and a subsequent divi-
sion in which equational division of sister chromatids re-
sults in a haploid oocyte and a second polar body. The
MATs are predicated upon the coordinated activities of the
spindle checkpoint [16,17], the anaphase-promoting
complex (APC) or cyclosome [18,19], the proteasome
[20,21], and the cohesion-complex proteins involved
with chromosome cohesion and separation [22–24]. Al-
terations in the temporal sequence of these coordinated
activities may potentially predispose cells to faulty chro-
mosome segregation.
Abnormal chromosome segregation has been observed in
mice lacking the Mad2 checkpoint protein [25]. The spin-
dle checkpoint utilizes sensory proteins that detect kineto-
chore-microtubule tension and occupancy and transiently
block anaphase until all of the chromosomes are properly
attached to microtubules [16,26,27]. Although the mam-
malian spindle checkpoint appears to differ between mi-
tosis and meiosis, the two meiotic divisions, and male and
female germ cells [28], anaphase subsequently follows
stable kinetochore-microtubule attachments [17,29] in
both vertebrate mitotic [30] and meiotic [31] cells.
The APC is a large protein complex that ubiquinates mi-
totic cyclins and other regulatory proteins that are des-
tined for timely proteolysis by proteasomes [10,20].
Proteasomes are multicatalytic 26S proteases consisting of
a 20S central core catalytic subunit bordered by two 19S
components [32,33] which hydrolyze C-terminal peptide
bonds to acidic, basic, and hydrophobic amino-acid resi-
dues [20,34]. Proteasomes proteolyze securins which in-
hibit separase activity. Separase is needed for inactivating
cohesions and enabling sister chromatid separation [35–
37] in both fission yeast [38] and mammalian cells [39].
Although differences have been reported among species
[40] and cell types [41], it appears that the majority of co-
hesion is removed from mammalian chromosomes dur-
ing prophase and prometaphase; whereas, a lesser
amount remains at kinetochores until anaphase onset.
Proteasomes translocated to meiotic spindles of rat
oocytes and MG-132 induced-inhibition of proteasomal
activity resulted in partial segregation of chromosomes
during meiosis I [42]. Moreover, defective proteasomal ac-
tivity in fission yeast impaired chromosome segregation
[38].
To test the hypothesis that transient inhibition of protea-
somal activity during mouse meiosis I was associated with
chromosome missegregation, mouse oocytes were ex-
posed in vitro to the reversible proteasome inhibitor MG-
132 and metaphase II (MII) oocytes were analyzed for
structural and numerical chromosome aberrations. This
transient arrest of proteasomal activity represents a pertur-
bation during the normal temporal sequence of events
during OM.
Results
Transient exposure of mouse oocytes to MG-132 for 6 h
followed by washout of the compound and an additional
17 h culture in vitro enabled exposure of cells during mei-
osis I and sufficient time for them to progress to met-
aphase II. Although the majority of MII oocytes were
classified as normal (Fig. 1A), the data indicated that MG-
132 induced a dose-response perturbation or delay in the
rate of OM and an increase of single, unpaired chromatids
and hyperploidy in MII oocytes (Table 1I). The significant
(P < 0.01) increase in the proportion of MI oocytes (Fig.
1B) in the 10.0 mcg/ml group relative to the other groups
and the significant (P < 0.01) decrease of oocytes exhibit-
ing premature centromere separation (PCS) (Fig. 1C) in
the 10.0 mcg/ml group relative to the controls suggest that
proteasomal inhibition retarded the rate of OM. An in-
verse relationship has been shown to exist between the
proportions of arrested MI oocytes and MII oocytes exhib-
iting PCS [43]. The significant (P < 0.01) dose responses
of higher frequencies of MII oocytes with single chroma-
tids (Figs. 1C,1E) and of hyperploidy (Figs. 1D,1E) sug-
gest that the MG-132-induced transient inhibition of
proteasomal and calpain activities during meiosis I pre-
disposed oocytes to abnormal chromosome segregation.Cell & Chromosome 2002, 1 http://www.cellandchromosome.com/content/1/1/2
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When oocytes were continuously exposed to 0.0, 0.5, 5.0,
25.0 or 50.0 g/ml MG-132 from one h after initiating the
culture until 17 h later, the proportions of MI arrested
oocytes were 5.7% (5/87), 12.3% (14/114), 39.3% (44/
112), 100% (98/98), and 100% (91/91), respectively. Of
the MI oocytes in the 25.0 and 50.0 g/ml MG-132
groups, 68.2% (30/44) and 100% exhibited diffuse chro-
matin (Fig. 1F); whereas, those oocytes continuously ex-
posed to 0.0, 0.5 or 5.0 g/mlMG-132 did not display
diffuse chromatin. Additionally, the proportions of MI
oocytes displaying homologue separation (Figs. 1G,1H)
in oocytes transiently exposed to MG-132 for 6 h were 0%
(0/13), 0% (0/19), 11.5% (3/26), 15.1% (8/53), respec-
tively for 0.0, 5.0, 7.5, and 10.0 g/mlMG-132. Oocytes
with premature anaphase, polyploidy, or structural chro-
mosome aberrations were not found.
Discussion
Proteasome activity is required for germinal vesicle break-
down (GVBD) in starfish and toad oocytes [44,45] and for
activating Xenopus oocytes [45,46]. Also, proteasomes are
needed for regulating centrosome segregation [38,47], ki-
netochore structure [39], and sister chromatid cohesion
and separation [48]. When rat oocytes were exposed to the
proteasome inhibitor MG132, proteasomes translocated
to the meiotic spindle, MPF activity was sustained, and
oocytes were arrested in MI with partially segregated chro-
mosomes [42].
Besides inhibiting proteasome activity, the peptide alde-
hyde proteasome inhibitors have been also reported to re-
press certain lysosomal cysteine proteases and calpains
[49]. The finding that MG-132 can obstruct the casein de-
grading activity of the calcium-dependent protease cal-
pain [50] appears relevant to oocyte maturation. Calpain
activity is needed for proteolysis of the c-mos proto-onco-
gene product pp39 mos in Xenopus oocytes [51], certain
cytoskeletal proteins (alpha-tubulin, actin, dynamin, lam-
in B) in starfish oocytes [52], and of cyclin in Xenopus egg
extracts [53].
We report that exposure of mouse oocytes to 10.0 mcg/ml
MG-132 during meiosis I led to significant (P < 0.01) in-
creases in the proportions of MI arrested oocytes and of
MII oocytes with SC and hyperploidy. Coupled with these
findings was a significant (P < 0.01) decrease in the inci-
dence of MII oocytes exhibiting PCS (Table 1). Chemical
induction of MI arrest in mammalian oocytes and sper-
matocytes indicates cell cycle retardation which is often
associated with aneuploidy [43,54]. Although 10.0 mcg/
ml MG-132 increased the frequency of MI arrested
oocytes, this cell-cycle retardation may not be entirely at-
tributed to proteasome inhibition. MG-132 can also in-
hibit calpains [50] which are needed for cell cycle
progression [52] and cyclin degradation [53]. Previous
studies [5,55] have shown that an inverse relationship
usually exists between the proportions of arrested MI
oocytes and MII oocytes exhibiting PCS. Oocytes residing
in MII for longer periods of time tend to display higher
frequencies of PCS; whereas, those deferred in MI spend
less time in MII prior to fixation. The significant (P < 0.01)
increase in the proportions of MII oocytes exhibiting PCS
in controls relative to the 10.0 g/ml group reflects the
greater length of time that control oocytes spent in MII
prior to fixation. We suggest that the PCS detected in MII
Figure 1
Cytogenetic analysis of mouse oocytes following in
vitro exposure to MG-132, chromosome configura-
tions are shown. (A) metaphase II oocyte, normal, n = 20
dyads. (B) metaphase I oocyte, normal, N = 20 tetrads. (C)
metaphase II oocyte, hypoploid, premature centromere sepa-
ration (incomplete), n = 19 1/2 (10 dyads and 19 chroma-
tids), arrow points to one of the 19 single, unpaired
chromatids. (D) metaphase II oocyte, hyperploid, n= 22
dyads. (E) metaphase II oocyte, hyperploid, single-unpaired
chromatid, n = 20 1/2 (20 dyads and one single, unpaired
chromatid indicated by arrow). (F) metaphase I oocyte, dif-
fuse chromatin, N= 20 probable tetrads. (G) metaphase I
oocyte, homologue separation, N= 20 (17 tetrads and 6
dyads), arrow points to one of the 6 dyads. (H) metaphase I
oocyte, homologue separation, N= 19 1/2 (16 tetrads and 7
dyads).
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oocytes mainly resulted from in vitro aging. As such, the
frequencies of PCS noted in Table 1 would represent inde-
pendent events relative to the other cytogenetic abnormal-
ities reported.
On the other hand, PCS during meiosis I can result in ane-
uploid MII oocytes. PCS of homologous chromosomes
and sister chromatids prior to establishing proper kineto-
chore-spindle attachment during meiosis I increases the
probabilities of both homologues going to the same pole
and of equational division of sister chromatids during an-
aphase I. Upon normal fertilization, MII oocytes with an
additional chromosome result in trisomic zygotes; where-
as oocytes containing an extra chromatid would be ex-
pected to produce 50% trisomic zygotes due to random
segregation during anaphase II. This situation also applies
to oocytes missing chromosomes and chromatids. Exper-
imental data support PCS as a prelude to aneuploidy. PCS
of homologues during meiosis I and equational division
of sister chromatids during anaphase I [56,57] and prema-
ture separation of chromatids during meiosis II [58,59]
and mitosis [60,61] have been shown to increase the inci-
dence of aneuploidy in subsequent divisions. The partial-
ly segregated chromosomes found in rat oocytes exposed
to MG-132 may have represented homologous chromo-
somes and/or sister chromatids [42].
The origin of single, unpaired chromatids in MII oocytes
has been proposed to result from premature separation of
sister chromatids prior to anaphase I [56,57]. The possi-
bility exists that both SC and aneuploidy may have origi-
nated from PCS of homologues and sister chromatids
during the MAT of meiosis I. Upon removal of MG-132
from the culture media during meiosis I and the subse-
quent resumption of OM and proteasomal activity, faulty
kinetochore-microtubule attachment accompanied by
degradation of cohesion proteins could conceivably lead
to PCS of homologues and sister chromatids. Following
anaphase I, a probability exists that both homologues and
sister chromatids could randomly assort to the same pole
and result in SC and aneuploid MII oocytes.
Although the frequency of homologue separation in-
creased with MG-132 dose, the sample size of 11 oocytes
is much too low to comment about their possible origin
or their influence on other abnormalities detected in MII
oocytes. The possibility exists that the observed homo-
logue separation may actually reflect anaphase onset. The
finding of diffuse chromatin in MI oocytes continuously
exposed to 25.0 and 50.0 g/mlMG-132 may be related to
the sustained elevation of MPF activity noted in rat
oocytes exposed to MG-132 [42] and the stabilization of
polyubiquitinated proteins and enhanced deubiquitina-
tion of nucleosomal histones in chromatin following pro-
teasomal inhibition [62].
Conclusions
The findings of the present study indicate that transient in
vitro exposure of mouse oocytes to MG-132 is associated
with abnormal chromosome segregation. However, addi-
tional data are clearly needed to further investigate the
roles of calpain proteolysis and proteasome-mediated
proteolysis on chromosome segregation as well as the nu-
merous other potential molecular mechanisms of aneu-
ploidy.
Methods
Animals
Female, ICR (Harlan Sprague-Dawley, Indianapolis, IN)
mice between 26–33 g (8–12 wks of age) were used in all
experiments. They were housed under ambient tempera-
ture of 21–23C, relative humidity of 50  5%, and a 12-
h light/12-h dark photoperiod. Feed and water were pro-
vided ad libitum. This research was approved by the Loui-
siana State University Health Sciences Center Animal
Resources Advisory Committee.
Oocyte collection, culture and exposure to MG-132
For each replicate experiment, five similarly treated mice
received an intraperitoneal injection of 7.5 IU pregnant
mare serum gonadotrophin (Dr. A.F. Parlow, National
Hormone & Peptide Program, Torrance, CA) to augment
the number of maturing follicles. Forty-six h later, the
mice were euthanized by CO2 inhalation and their repro-
ductive tracts placed into Waymouth culture medium
Table 1: Cytogenetic analysis of mouse metaphase II oocytes following in vitro exposure to the proteasome inhibitor MG-132
MG-132 
(mcg/ml)
No. cells 
analyzed
No. MI oocytes 
(%)
No. MII oocytes 
(%)
No. premature centromere 
separation (%)
No. single chromatids 
(%)
No. haploid (%) No. hypoploid 
(%)
No. hyperploid 
(%)
Control 130 13 (10.0)a 117 (90.0) 43 (36.8)a 1 (0.9)a 101 (86.3) 16 (13.7) -0-a
5.0 158 19 (12.0)a 139 (88.0) 38 (27.3) 3 (2.2)a,b 121 (87.1) 18 (12.9) -0-a
7.5 191 26 (13.6)a 165 (86.4) 44 (26.7) 11 (6.7)b 142 (86.1) 18 (10.9) 5 (3.0)b
10.0 125 53 (42.4)b 72 (57.6) 13 (18.1)b 11 (15.3)c 62 (86.1) 3 (4.2) 7 (9.7)c
Different superscripts among proportions in the same column indicate significant (P < 0.01) differences.Cell & Chromosome 2002, 1 http://www.cellandchromosome.com/content/1/1/2
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(Gibco, Grand Island, New York, No. 11220-035). The
ovaries were isolated and cumulus-oocyte complexes
(COC) were liberated from antral follicles. The COC were
then transferred to a 35  15 mm culture dish (Falcon No.
1008; Becton Dickinson, Co., Lincoln Park, NJ) contain-
ing 3 ml of complete culture medium (Waymouth medi-
um, 942.7 ml, [Gibco No. 11220-035]; fetal bovine
serum, 50 ml, [Gibco No. 16000-036]; penicillin-strepto-
mycin [10,000 U/ml each of penicillin G sodium and
streptomycin sulphate, 5 ml, [Gibco No. 15140-122];
pyruvic acid, 2.3 ml [Gibco No. 11360-070]; and 1 g/ml
FSH [NHPP, lot AFP-7028D]) and incubated at 37C in a
5% CO2 gaseous atmosphere. A stock solution of 150 g/
ml MG-132 (Z-leu-leu-CHO; Calbiochem, La Jolla, CA;
No. 474790) was prepared in Waymouth medium con-
taining 7.5 L per ml. dimethylsulfoxide (DMSO) as the
solvent.
MG-132 is a peptide aldehyde that inhibits ubiquitin-me-
diated proteolysis by binding to and inactivating 20S and
26S proteasomes [49,62]. Although 1–10 M MG-132 in-
hibited first polar body extrusion in rat oocytes, its activity
is reversible [42]. We conducted preliminary experiments
to obtain a MG-132 dose range that would transiently per-
turb or inhibit OM during meiosis I while enabling
oocytes to complete OM following washing out of the
compound. Data from oocytes cultured in either 0.0, 0.5,
5.0, 25.0, or 50.0 g/ml MG-132 from one h after initiat-
ing the culture until 17 h later showed that the two higher
doses completely blocked oocytes in MI. On the other
hand, when oocytes were exposed to these same MG-132
doses from one h after initiating the culture until 6 h later
when the chemical was washed out (4X) and cultured for
an additional 17 h in media without MG-132, oocytes ex-
posed to 25.0 and 50.0 g/ml MG-132 were still arrested
in MI. Thus, data from these preliminary experiments en-
abled the selection of a protocol in which oocytes were
placed into complete culture media and incubated for 1 h
prior to adding either 0 (solvent only), 5.0, 7.5, or 10.0
g/ml MG-132. Six h later, the MG-132 was washed out of
the media by rinsing the oocytes four times in complete
media without MG-132 and then re-incubated for 17 h.
Under this protocol, oocytes were exposed to MG-132
during meiosis I and the subsequent 17 h culture time
provided sufficient time for the oocytes to overcome the
MG-132-induced meiotic block and progress to MII. Con-
trol oocytes were cultured in 7.5 l DMSO per ml com-
plete media and processed in the same manner as those
exposed to MG-132.
Cytogenetic analysis and statistical analysis of data
Oocytes were collected and processed according to a
mass-harvest procedure [63] and chromosomes were C-
banded [64] to distinguish between complete dyads (MII
chromosomes) and disjoined dyads (single chromatids).
In each cell analyzed, the number of chromosomes and/
or chromatids was counted at 1000  magnification to
provide data for calculating aneuploidy. The number of
hypoploid (n = 10–19 1/2), haploid (n = 20), hyperploid
(n = 20 1/2–29 1/2), and polyploid (n = 30–40) MII
oocytes were recorded. An oocyte classified as 20 1/2 con-
tains 20 dyads and one chromatid or one-half dyad. The
frequencies of each ploidy class were divided by the total
number of MII oocytes analyzed excluding polyploidy.
The frequencies of MII oocytes displaying premature cen-
tromere separation (PCS), single chromatids (SC), prema-
ture anaphase (PA) were also calculated relative to the
total number of MII oocytes analyzed. Since MI and poly-
ploid oocytes are distinct categories and are disregarded
when computing aneuploidy, their frequencies were cal-
culated relative to the total number of oocytes analyzed.
The criteria for eliminating a cell from analysis included:
inadequate C-banding for discriminating between intact
dyads and those separated at the centromere, overlapped
or clumped chromosomes, or excessive chromosome scat-
ter that precluded an objective analysis of numerical or
structural aberrations. The frequencies of hyperploid cells
were used as a measure of aneuploidy because an un-
known proportion of the hypoploid cells is influenced by
technical artifact resulting from excessive chromosome
scatter during slide preparation. Chi-Square analysis and
the Fisher's Exact Test were used for data analyses.
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